Literature DB >> 1324770

Increased densities of binding sites for the 'peripheral-type' benzodiazepine receptor ligand [3H]PK 11195 in rat brain following portacaval anastomosis.

J F Giguère1, E Hamel, R F Butterworth.   

Abstract

Using quantitative receptor radioautography, binding sites for the 'peripheral-type' benzodiazepine receptor ligand [3H]PK 11195 were studied in rats 4 week after end-to-side portacaval anastomosis and in sham-operated controls. Portacaval anastomosis resulted in region-selective increases in density of [3H]PK 11195 binding sites in cerebellum, pons greater than thalamus, cerebral cortex greater than hippocampus greater than striatum. Possible mechanisms implicated in these changes include (i) the action of endogenous ligands for the mitochondrial benzodiazepine receptor such as octadecaneuropeptide and (ii) neurotoxic actions of ammonia. In view of the proposed role of these receptors as modulators of intermediary metabolism and neurosteroid biosynthesis, such changes could contribute to the neurochemical mechanisms responsible for portal-systemic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324770     DOI: 10.1016/0006-8993(92)91222-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

Review 1.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

3.  Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

Authors:  R M Audet; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 4.  Metal toxicity, liver disease and neurodegeneration.

Authors:  Roger F Butterworth
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

Review 5.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

6.  Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.

Authors:  V L Rao; R Audet; G Therrien; R F Butterworth
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 7.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

Review 8.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

9.  Benzodiazepine-like substances and hepatic encephalopathy : implications for treatment.

Authors:  J A Cossar; P C Hayes; R E O'Carroll
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 10.  Effects of hyperammonaemia on brain function.

Authors:  R F Butterworth
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.